Cargando…
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
BACKGROUND: Despite rigorous confirmation with reliable assays, some individuals showing the neuromyelitis optica spectrum disorder (NMOSD) phenotype remain negative for both aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies. OBJECTIVE: We aimed to investigate whether doubl...
Autores principales: | Hyun, Jae-Won, Kim, Yeseul, Kim, Ki Hoon, Kim, Su-Hyun, Olesen, Mads Nikolaj, Asgari, Nasrin, Siritho, Sasitorn, Paul, Friedemann, Kim, Ho Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006458/ https://www.ncbi.nlm.nih.gov/pubmed/35413922 http://dx.doi.org/10.1186/s12974-022-02450-w |
Ejemplares similares
-
Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis
por: Srikajon, Jindapa, et al.
Publicado: (2018) -
Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
por: Asgari, Nasrin, et al.
Publicado: (2017) -
Effect of plasma exchange in neuromyelitis optica spectrum disorder: A systematic review and meta‐analysis
por: Kosiyakul, Punchika, et al.
Publicado: (2020) -
Investigating the Presence of Interattack Astrocyte Damage in Neuromyelitis Optica Spectrum Disorder: Longitudinal Analysis of Serum Glial Fibrillary Acidic Protein
por: Hyun, Jae-Won, et al.
Publicado: (2021) -
Efficacy and safety of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis
por: Songwisit, Sakdipat, et al.
Publicado: (2020)